Captured between 2026-10-24T20:12:19.245Z and 2026-10-24T20:12:19.257Z. This is a captured core record, not a reconstruction of an arbitrary earlier moment.
Status: published
A clinical trial evaluating Ebola vaccines has started in the Democratic Republic of the Congo. One trial involves Ervebo, a vaccine approved against the Zaire strain, to assess whether it provides cross-protection against the Bundibugyo strain, alongside tests of multiple vaccines for safety, efficacy, and immunogenicity. It is not yet reported how many participants will be enrolled or when initial findings will be released.
Category: disease-outbreak · Location: Democratic Republic of the Congo
No published correction or update is recorded. This does not reconstruct changes made before correction records were kept.
Global Event Monitor. Ebola vaccine clinical trial begins in DR Congo. 2026-10-24T01:10:03.159Z. Status: published. urn:global-events-monitor:event:7283. https://global.eventmonitor.net/record/7283/revision/ec98a74de912d2238a4d47b70e62783a3d3a31a2a6104ecbd3a6b8ff353be9a4
BibTeX · RIS · CSV · JSON · Corrections and updates · Captured versions
Current event record · Captured revision history
SHA-256: ec98a74de912d2238a4d47b70e62783a3d3a31a2a6104ecbd3a6b8ff353be9a4. A digest detects a changed payload; it is not an externally witnessed timestamp.